(Reuters) – Auxilium Pharmaceuticals Inc reported a big fall in quarterly sales in the United States for both its drugs, and said it acquired Actient Holdings LLC to bolster its urology business.
LONDON (Reuters) – A spike in U.S. demand for flu drug Tamiflu and strong sales of mainstay cancer medicines lifted first-quarter sales at Roche Holding AG by a bigger-than-expected 5 percent.
WASHINGTON (Reuters) – The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off the market.
LONDON, March 22 – New multiple sclerosis drugs from Biogen Idec and Sanofi have been recommended for approval in Europe.
LONDON (Reuters) – The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to the chief executive of GlaxoSmithKline Plc.
NEW YORK (Reuters) – Michael Weitz was out of options. The Californian had endured chemotherapy, radiation and surgery but his lung cancer still spread to his bones and brain.
CHICAGO (Reuters) – Proposed U.S. guidelines may make it easier for drug companies to test Alzheimer’s treatments in people at an earlier stage, when scientists think they may have the best shot at working.
WASHINGTON (Reuters) – Patients stepping into Johns Hopkins University’s HIV clinic in east Baltimore do not just see a doctor or get prescriptions for their antiretroviral drugs. Many also get help finding a place to live or bus fare to … Continue reading
NEW YORK (Reuters Health) – Consumer beware: When prescription drugs become available over-the-counter, advertisers start spotlighting the benefits and downplaying the risks, a new study finds.
ZURICH (Reuters) – Swiss drugmaker Roche Holding AG believes the threat from so-called biosimilar copies of its cancer drugs has been pushed back as companies developing the cut-price biotech medicines face development hurdles.